<?xml version="1.0" encoding="UTF-8"?>
<p id="Par11">Although we mainly focus on strategies targeting virus-NAb complex binding to FcR, it is possible that the virus-NAb complex may also initiate inflammatory responses through the classical pathway of the complement system, which may be blocked through C5- and C5a-targeted inhibition (Horiuchi and Tsukamoto 
 <xref ref-type="bibr" rid="CR12">2016</xref>).
</p>
